UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002971
Receipt number R000003604
Scientific Title Effects of anti-platelet agents on the patients after surgery of the pancreatic cancer as the adjuvant therapy (pilot study)
Date of disclosure of the study information 2010/01/15
Last modified on 2013/01/07 19:52:19

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of anti-platelet agents on the patients after surgery of the pancreatic cancer as the adjuvant therapy (pilot study)

Acronym

Effects of anti-platelet agents on the pancreatic cancer after surgery

Scientific Title

Effects of anti-platelet agents on the patients after surgery of the pancreatic cancer as the adjuvant therapy (pilot study)

Scientific Title:Acronym

Effects of anti-platelet agents on the pancreatic cancer after surgery

Region

Japan


Condition

Condition

pancreatic cancer

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effects of anti-platelet agents on the patients after the curative resection of the pancreatic cancer as the adjuvant therapy.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Phase I,II


Assessment

Primary outcomes

Disease-free survival

Key secondary outcomes

Overall survival


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

with aspirin

Interventions/Control_2

without aspirin

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

after the curative resection of the pancreatic cancer

Key exclusion criteria

metastasis, inoperable cases

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Minoru Kitago

Organization

Department of Surgery, Keio University School of Medicine

Division name

Department of Surgery

Zip code


Address

Shinanomachi 35, Shinjuku-ku

TEL

03-3353-1211(ext62529)

Email



Public contact

Name of contact person

1st name
Middle name
Last name Minoru Kitago

Organization

Department of Surgery, Keio University School of Medicine

Division name

Department of Surgery

Zip code


Address

Shinanomachi 35, Shinjuku-ku

TEL

03-3353-1211(ext62529)

Homepage URL


Email



Sponsor or person

Institute

Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Bayer HealthCare

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院


Other administrative information

Date of disclosure of the study information

2010 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 11 Month 13 Day

Date of IRB


Anticipated trial start date

2010 Year 01 Month 01 Day

Last follow-up date

2012 Year 09 Month 30 Day

Date of closure to data entry

2012 Year 09 Month 30 Day

Date trial data considered complete

2012 Year 09 Month 30 Day

Date analysis concluded

2012 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2010 Year 01 Month 04 Day

Last modified on

2013 Year 01 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003604


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name